Tendon Rupture in Plaintiff's Patellar Tendon
Frass claims that she began taking the antibiotic Levaquin in April of 2005, and was diagnosed with a Levaquin tendon rupture in her right patellar tendon in September of that year after experiencing painful side effects including pain and swelling in her right knee. The symptoms began to show up shortly after she began taking Levaquin, and she and her Levaquin lawyer have linked her use of the drug to the tendon rupture.
Rupture of the patellar tendon almost always requires surgery to repair and also involves a significant period of rehabilitation and immobility. Frass and her Levaquin lawyer claim that as a consequence of her Levaquin tendon rupture, Frass has experienced side effects including significant pain, stiffness, swelling, inability to engage in the activities she once enjoyed, and a lack of independence.
Claims that Levaquin Drugmaker Downplayed Risks
Frass' lawsuit also claims that Johnson & Johnson, the manufacturer of Levaquin, downplayed the potential risk of Levaquin tendon injury and other Levaquin side effects and did not adequately inform either patients or medical professionals of the potential risk of side effects associated with the medication. Despite their apparent lack of warning in the United States about Levaquin risks, Johnson & Johnson distributed information about tendon rupture throughout Europe.
Frass and her Levaquin lawyer are seeking damages that could help cover tendon injuries experienced by the plaintiff, as well as special damages that could help cover medical bills past and future, rehabilitation, pain and suffering, and loss of income.
No comments:
Post a Comment